GAMMA Investing’s UroGen Pharma URGN Stock Holding History

GAMMA Investing’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$27K	Buy	664 +223	+51%	+$9.57K	﹤0.01%	2763
2026 Q2	$16.2K	Buy	441 +2	+0.5%	+$54	﹤0.01%	2955
2026 Q1	$7.89K	Buy	439 +87	+25%	+$1.74K	﹤0.01%	3185
2025 Q4	$8.24K	Sell	352 -22	-6%	-$477	﹤0.01%	3065
2025 Q3	$7.46K	Buy	374 +38	+11%	+$682	﹤0.01%	3012
2025 Q2	$4.6K	Sell	336 -342	-50%	-$3.28K	﹤0.01%	3156
2025 Q1	$7.5K	Buy	678 +571	+534%	+$6.09K	﹤0.01%	2885
2024 Q4	$1.14K	Buy	107 +26	+32%	+$311	﹤0.01%	3385
2024 Q3	$1.03K	Buy	81 +45	+125%	+$668	﹤0.01%	3248
2024 Q2	$604	Buy	36 +16	+80%	+$228	﹤0.01%	3170
2024 Q1	$300	Buy	+20	New	+$327	﹤0.01%	3179

Other funds holding URGN

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's URGN Position: Q3 2026 in Review

GAMMA Investing increased its UroGen Pharma (URGN) stake by 51% in Q3 2026, buying an estimated $9.57K and bringing the position to 664 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #2763.

GAMMA Investing first reported a position in URGN in Q1 2024 and has held it in 11 quarters since. 2 funds tracked by Wall St. Rank hold URGN as of Q3 2026.

GAMMA Investing held 664 shares of UroGen Pharma worth $27K as of Q3 2026.
GAMMA Investing bought 223 UroGen Pharma shares in Q3 2026, an estimated $9.57K.
UroGen Pharma made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2763 holding.
GAMMA Investing first reported a position in UroGen Pharma in Q1 2024 and has held it in 11 quarters since.
2 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.